PER 5.00% 7.6¢ percheron therapeutics limited

anp chart, page-890

  1. 12,787 Posts.
    lightbulb Created with Sketch. 1292
    yes Sam I did say that the Tox study will open doors .
    I should have clarified it better.
    What’s the primary news I wanted to post ?
    Yes Sam “ Ionis has stopped pursuing Acromegalia.
    Thats big news for Anp.

    Mac9 is correct when he said there is no Tox requirement for Atl1103 re Acromegalia
    I never said there was
    Confusion … Yes.
    I said once the Tox study was completed it would. Generate interest from Big Pharma.
    yes Sam
    That’s exactly what we did.
    “Sat around “ waiting for the result re Acromegaly from Ionis..
    No Pharma or Partner would look at us while Ionis was doing a trial in Acromeglia .

    Sam !
    Have you got a Science degree ?
    Have you got a Finance degree?
    Have you worked with Big Pharma ?
    Have you any experience in drug
    commercialisation ?
    Have you ever been on any Board Asx Coy’s ?
    No wonder you don’t see “eye to eye “ with JG
    You have been wasting Anp’s time over 10 years.
    And when the Anp Board don’t implement your ideas you Sulk and get nasty!
    “Oh I forgot James is the new Messiah Lol .. you have no idea”
    Says you ..
    So Sam .. tell us all .. Why do you think that JG can’t lead us to commercialisation and increase the sp x 20..
    Is he not the man for the CEO job..?



    I’m just curious and most on this thread are as well
    Last edited by itsagas: 07/10/23
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.6¢
Change
-0.004(5.00%)
Mkt cap ! $68.51M
Open High Low Value Volume
8.0¢ 8.0¢ 7.6¢ $201.6K 2.545M

Buyers (Bids)

No. Vol. Price($)
2 146314 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 106165 2
View Market Depth
Last trade - 16.10pm 09/05/2024 (20 minute delay) ?
Last
7.7¢
  Change
-0.004 ( 3.75 %)
Open High Low Volume
7.9¢ 8.0¢ 7.7¢ 79316
Last updated 15.57pm 09/05/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.